Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2014
Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injuryChristine Guo Lian, Ericka M Bueno, Scott R Granter, et al.Cell|July 4, 2006
Comparative oncogenomics identifies NEDD9 as a melanoma metastasis geneMinjung Kim, Joseph D Gans, Cristina Nogueira, et al.Cancer Cell|June 13, 2006
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancersIan J Davis, Jessica J Kim, Fatih Ozsolak, et al.Journal of Cutaneous Pathology|December 30, 2016
5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasmsJonathan J Lee, Ricardo E Vilain, Scott R Granter, et al.Plos One|June 4, 2010
Integrative genome comparison of primary and metastatic melanomasOmar Kabbarah, Cristina Nogueira, Bin Feng, et al.Molecular Cell|November 27, 2010
Intronic miR-211 assumes the tumor suppressive function of its host gene in melanomaCarmit Levy, Mehdi Khaled, Dimitrios Iliopoulos, et al.Current Biology : CB|February 8, 2005
BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanomaE Elizabeth Patton, Hans R Widlund, Jeffery L Kutok, et al.Nature|July 8, 2005
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanomaLevi A Garraway, Hans R Widlund, Mark A Rubin, et al.Clinical Epigenetics|July 30, 2015
Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomasJonathan J Lee, Lynette M Sholl, Neal I Lindeman, et al.Cancer Cell|July 12, 2011
Proinvasion metastasis drivers in early-stage melanoma are oncogenesKenneth L Scott, Cristina Nogueira, Timothy P Heffernan, et al.Pageof 8